Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893167287> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2893167287 abstract "265 Background: A key component of any Enhanced Recovery After Surgery (ERAS) program is standardized multimodal analgesia to minimize opioid use. Our program utilizes acetaminophen, nonsteroidal anti-inflammatory agents and gabapentanoids perioperatively. The primary aim of our study was to evaluate pregabalin use after surgery and impact on total morphine equivalent daily dose (MEDD). Methods: Data was collected retrospectively on consecutive ERAS patients who underwent open gynecologic surgery from 3/4/2016 through 2/22/2018. We excluded any patient identified as a chronic opioid user. Standard preoperative medications included 300 mg tramadol ER, 75 mg pregabalin, and 400 mg celecoxib per institutional guidelines. Standard postoperative pain regimen included scheduled oral acetaminophen, ibuprofen and pregabalin unless contraindicated with rescue oral oxycodone and IV hydromorphone as needed. Pregabalin was ordered 75 mg twice daily for 4 doses. Recommended exceptions to pregabalin included hypersensitivity or age greater than 65 years. Median and range were calculated to summarize continuous variables. Spearman’s rank was used to test the correlation between post-operative pregabalin dose and MEDD. Results: A total of 533 patients were included for analysis. Twelve patients were excluded for chronic opioid use. 38% of patients received all four post-operative pregabalin doses (207/533). 32.8% of patients received no pregabalin (175/533). The fourth dose was the most common missed dose (274/533, 51.4%). The top reasons dose 4 was missed included not being ordered (58.8%) and patient already discharged (12.4%). There were 202 patients older than 65 years, the majority of these patients received no post-operative pregabalin (123/202, 60.9%). There was no difference in the amount of MEDD between those who received all pregabalin doses compared to those who received none (90.75 mg [4-663.5 mg] vs 82.5 mg [4-634.5 mg]; p = 0.269). Conclusions: Pregabalin for preemptive analgesia in an ERAS program does not decrease MEDD." @default.
- W2893167287 created "2018-10-05" @default.
- W2893167287 creator A5000098403 @default.
- W2893167287 creator A5005179697 @default.
- W2893167287 creator A5019935261 @default.
- W2893167287 creator A5024272716 @default.
- W2893167287 creator A5024627306 @default.
- W2893167287 creator A5036110887 @default.
- W2893167287 creator A5062184522 @default.
- W2893167287 creator A5064499162 @default.
- W2893167287 date "2018-10-20" @default.
- W2893167287 modified "2023-10-12" @default.
- W2893167287 title "Use of pregabalin for preemptive analgesia in an enhanced recovery after surgery program." @default.
- W2893167287 doi "https://doi.org/10.1200/jco.2018.36.30_suppl.265" @default.
- W2893167287 hasPublicationYear "2018" @default.
- W2893167287 type Work @default.
- W2893167287 sameAs 2893167287 @default.
- W2893167287 citedByCount "0" @default.
- W2893167287 crossrefType "journal-article" @default.
- W2893167287 hasAuthorship W2893167287A5000098403 @default.
- W2893167287 hasAuthorship W2893167287A5005179697 @default.
- W2893167287 hasAuthorship W2893167287A5019935261 @default.
- W2893167287 hasAuthorship W2893167287A5024272716 @default.
- W2893167287 hasAuthorship W2893167287A5024627306 @default.
- W2893167287 hasAuthorship W2893167287A5036110887 @default.
- W2893167287 hasAuthorship W2893167287A5062184522 @default.
- W2893167287 hasAuthorship W2893167287A5064499162 @default.
- W2893167287 hasConcept C126322002 @default.
- W2893167287 hasConcept C141071460 @default.
- W2893167287 hasConcept C170493617 @default.
- W2893167287 hasConcept C2776029756 @default.
- W2893167287 hasConcept C2776468701 @default.
- W2893167287 hasConcept C2777389121 @default.
- W2893167287 hasConcept C2778722691 @default.
- W2893167287 hasConcept C2779158186 @default.
- W2893167287 hasConcept C2779777798 @default.
- W2893167287 hasConcept C2780820201 @default.
- W2893167287 hasConcept C2781063702 @default.
- W2893167287 hasConcept C2781413609 @default.
- W2893167287 hasConcept C42219234 @default.
- W2893167287 hasConcept C71924100 @default.
- W2893167287 hasConceptScore W2893167287C126322002 @default.
- W2893167287 hasConceptScore W2893167287C141071460 @default.
- W2893167287 hasConceptScore W2893167287C170493617 @default.
- W2893167287 hasConceptScore W2893167287C2776029756 @default.
- W2893167287 hasConceptScore W2893167287C2776468701 @default.
- W2893167287 hasConceptScore W2893167287C2777389121 @default.
- W2893167287 hasConceptScore W2893167287C2778722691 @default.
- W2893167287 hasConceptScore W2893167287C2779158186 @default.
- W2893167287 hasConceptScore W2893167287C2779777798 @default.
- W2893167287 hasConceptScore W2893167287C2780820201 @default.
- W2893167287 hasConceptScore W2893167287C2781063702 @default.
- W2893167287 hasConceptScore W2893167287C2781413609 @default.
- W2893167287 hasConceptScore W2893167287C42219234 @default.
- W2893167287 hasConceptScore W2893167287C71924100 @default.
- W2893167287 hasLocation W28931672871 @default.
- W2893167287 hasOpenAccess W2893167287 @default.
- W2893167287 hasPrimaryLocation W28931672871 @default.
- W2893167287 hasRelatedWork W2010706634 @default.
- W2893167287 hasRelatedWork W2013732498 @default.
- W2893167287 hasRelatedWork W2334422892 @default.
- W2893167287 hasRelatedWork W2561089364 @default.
- W2893167287 hasRelatedWork W2772467878 @default.
- W2893167287 hasRelatedWork W2893167287 @default.
- W2893167287 hasRelatedWork W3011014277 @default.
- W2893167287 hasRelatedWork W3138186470 @default.
- W2893167287 hasRelatedWork W4280491243 @default.
- W2893167287 hasRelatedWork W4280600910 @default.
- W2893167287 isParatext "false" @default.
- W2893167287 isRetracted "false" @default.
- W2893167287 magId "2893167287" @default.
- W2893167287 workType "article" @default.